Louise Buur

Title: Louise Buur: Innovator in Pharmaceutical Compositions

Introduction

Louise Buur is a prominent inventor based in Valby, Denmark. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of synucleinopathies. With a total of four patents to her name, her work focuses on innovative compositions and methods that aim to improve patient outcomes.

Latest Patents

Among her latest patents, Louise has developed stable and low viscosity liquid pharmaceutical compositions that comprise antibodies binding to human alpha synuclein. These inventions are crucial for treating synucleinopathies or prodromal synucleinopathy. The patents detail suitable doses and dosing regimens for these antibodies, which can be formulated in the stable and low viscosity liquid compositions she has created.

Career Highlights

Louise Buur is currently associated with H. Lundbeck A/S, a company known for its dedication to improving the lives of people with brain diseases. Her work at Lundbeck has positioned her as a key player in the pharmaceutical industry, particularly in the development of treatments for neurological disorders.

Collaborations

Louise has collaborated with notable colleagues, including Josefine Nielsen Søderberg and Pekka Kallunki. These partnerships have enhanced her research and contributed to the advancement of her innovative projects.

Conclusion

Louise Buur's contributions to the field of pharmaceuticals, particularly in the treatment of synucleinopathies, highlight her role as an influential inventor. Her patents and collaborations reflect her commitment to advancing medical science and improving patient care.